CIK 0001776985 · Large accelerated filer
BioNTech SE
Sign in to watch- Ticker
- BNTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Germany
- Entity type
- other
- Phone
- 0049613190840
- Business address
- AN DER GOLDGRUBE 12, MAINZ, Germany, 55131
- 6-K Event Report of Foreign Issuer
- 4 Planned sale Chief Executive Officer sold 20,500 shares at $96.31 ($1,974,287)
- 4 Planned sale Chief Executive Officer sold 73,000 shares at an average $98.50 ($7,190,663)
- 4 Planned sale Chief Executive Officer sold 76,500 shares at an average $103.12 ($7,889,055)
- 144 Insider Sale of Securities
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 20-F/A Report Annual and Transition Report of Foreign Private Issuers
- 6-K Event Report of Foreign Issuer
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 2 of 30 · 590 filings